Login Register Cart 0
Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Dual Component Tablets for the Treatment of Gastroesophageal Reflux Disease

Author(s): Shalinee Jain, Ankit Namdev and Dharmendra Jain*

Volume 9, Issue 1, 2019

Page: [69 - 78] Pages: 10

DOI: 10.2174/2210303108666181010110215

Price: $65

Abstract

Background and Objective: Gastroesophageal reflux disease (GERD) is one of the most common GIT disorders in which reflux of the GIT contents occurs into the esophagus. The present study is focused on developing a dual component tablet containing a sustained release floating layer of Baclofen and delayed release microspheres of Rabeprazole sodium for the effective treatment of Gastroesophageal Reflux Disease (GERD).

Methods:Dual component tablets have been developed to achieve a controlled delivery of two different drugs. Microspheres were prepared by the emulsion solvent evaporation method using different ratios of Eudragit S100 and Rabeprazole sodium (3:1, 6:1, 9:1 and 12:1) and optimized using various parameters. Baclofen floating tablets were prepared by the wet granulation method by using different polymers like sodium alginate (S1), pectin (S2) and guar gum (S3) and characterized for their floating properties and in-vitro drug release study.

Results: The cumulative percentage drug release after 9 hrs was found to be in the range of 46.18 to 65.78% for different microsphere formulations. The result showed that, as the amount of polymer increased, the particle size and % yield were also increased, and drug release and entrapment efficiency were decreased. Among all the formulations, M2 was considered as the best because it showed highest entrapment efficiency. Among baclofen floating tablet formulations, S1 was resulted as optimized formulation because it sustained the drug release up to 8 hrs and showed 64.82±0.82% drug release.

Conclusion: From the above optimized formulations bilayer tablets containing floating layer of Baclofen and Rabeprazole sodium loaded microspheres layer were prepared by single-punch tablet machine and evaluated for the weight variation, hardness, thickness, diameter, friability, floating time etc. The results of the study showed that all parameters were within pharmacopoeial limits.

Keywords: Dual component, sustained, floating tablet, microspheres, drug release, gastroesophageal reflux.

« Previous
Graphical Abstract

[1]
Lee, Y.Y.; McColl, K.E. Pathophysiology of gastroesophageal reflux disease. Best Pract. Res. Clin. Gastroenterol., 2013, 27, 339-351.
[2]
Kahrilas, P.J. GERD pathogenesis, pathophysiology, and clinical manifestations. Cleve. Clin. J. Med., 2013, 70, S4-S5.
[3]
Vaezi, M.F.; Richter, J.E. Role of acid and duodenogastroesophageal reflux ingastroesophageal reflux disease. Gastroenterol, 1996, 111, 1192-1199.
[4]
Pant, S.; Badola, A.; Kothiyal, P. A review on gastroretentive drug delivery system. Int. J. Res. Dev. Pharm. Life Sci, 2016, 5, 2178-2187.
[5]
Patel, T.; Ajay, T.; Kumar, S.; Jadhav, A. Formulation, optimization and evaluation of raft forming tablet of Nizatidine. Indo. Am. J. Pharm. Res, 2015, 5, 1178-1179.
[6]
Devtalu, S.V.; Patil, A.E.; Baril, M.M.; Barhate, S.D. A review on novel approach-Bilayer tablet technology. Int. J. Pharm. Sci. Rev. Res., 2013, 21, 46-52.
[7]
Abebe, A.; Akseli, I.; Sprockel, O.; Kottala, N.; Cuitino, A.M. Review of bilayer tablet technology. Int. J. Pharm., 2014, 461, 549-558.
[8]
Deshpande, R.D.; Gowda, D.V.; Mahammed, N.; Maramwar, D.N. Bilayer tablet- An emerging trend: A review. Int. J. Pharm. Sci. Res., 2011, 2, 2534-2544.
[9]
He, W.; Li, Y.; Zhang, R.; Wu, Z.; Yin, L. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: Preparation and in vitro/in vivo evaluation. Int. J. Pharm., 2014, 476, 223-231.
[10]
Kaur, B.; Sharma, S.; Sharma, G.; Saini, R.; Singh, S.; Nagpal, M.; Jain, U.K.; Sharma, M. A review of floating drug delivery. Asian J. Biomed. Pharm. Sci, 2013, 3, 2249-2622.
[11]
Singh, A.K.; Dubey, V.; Arora, V. Role of natural polymer use in floating drug delivery system. J. Pharma. Sci. Innov, 2012, 3, 11-15.
[12]
Jain, D.; Bar-Shalom, D. Alginate drug delivery systems: Application in context of pharmaceutical and biomedical research. Drug Dev. Ind. Pharm., 2014, 40, 1576-1584.
[13]
Hampson, F.C.; Jolliffe, I.G.; Bakhtyari, A.; Taylor, G.; Sykes, J.; Johnstone, L.M.; Dettmar, P.W. Alginate-antacid combinations: Raft formation and gastric retention studies. Drug Dev. Ind. Pharm., 2010, 36, 614-623.
[14]
Pawar, A.Y.; Jadhav, K.R.; Nikam, M.N. A raft forming system. A novel approach for Gastroretention. Int. J. Pure. Appl. Biosci, 2015, 3, 178-192.
[15]
Prajapati, B.; Jena, V.K.; Mehta, T.; Seshadri, S. Preparation and optimization of moxifloxacin microspheres for colon targeted delivary using quality by design approach: In vitro and in vivo study. Curr. Drug Deliv., 2016, 13, 1021-1033.
[16]
Morishita, I.; Morishita, M.; Takayama, K.; Machida, Y.; Nagai, T. Enteral insulin delivary by microspheres in three different formulations using eudragit S100 and L100. Int. J. Pharm., 1993, 91, 29-37.
[17]
Hershcovici, T.; Fass, R. Pharmacological management of GERD: Where does it stand now? Trends Pharmacol. Sci., 2011, 32, 258-262.
[18]
Chukka, S. Shayeda. Development and in vitro evaluation of Baclofen floating tablet using different natural polymers. Int. J. Pharm. Pharm. Res, 2016, 7, 293-306.
[19]
Tank, N.A.; Kumar, G.S.; Kalyani, P.; Tank, N.A.; Dhaval, P. Formulation and in vitro evaluation of enteric microspheres of Rabeprazole sodium. Res. J. Pharm. Biol. Chem. Sci., 2011, 2, 780-789.
[20]
Alanazi, F.K.; Bagori, E.L.; Alsarra, A.; Bayomi, M.A.; Abdel, K.M. Saudi- Corn starch as a tablet excipient compared with imported starch. Saudi Pharm. J., 2008, 16, 112-121.
[21]
Raj, B.S. Shanthi.; Nair, R.S.; Samraj, P.I.; Vidya. Formulation and evaluation of coated microspheres for colon targeting. J. Appl. Pharm. Sci., 2013, 3, S68-S74.
[22]
Subudhi, M.B.; Jain, A.; Jain, A.; Hurkat, P.; Shilpi, S.; Gulbake, A.; Jain, S.K. Eudragit S100 coated citrus pectin nanoparticals for colon targeting of 5-fluorouracil. Materials, 2015, 8, 832-849.
[23]
Ranpise, N.S.; Kolhe, S.R.; Ranade, A.N. Development and evaluation of bilayer gastroretentive floating drug delivery system for Baclofen. Indian J. Pharm. Edu. Res, 2012, 47, 41-46.
[24]
Swapna, B.D.; Abhinay, D. Formulation and evaluation of bilayer tablets of salbutamol sulphate and cetrizine for the treatment of asthma. World J. Pharm. Pharm. Sci., 2014, 3, 1144-1157.

Rights & Permissions Print Cite
Article Metrics
34
1
© 2024 Bentham Science Publishers | Privacy Policy